Times Square Capital Management, LLC Novo Nordisk A S Transaction History

Times Square Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $70,224 - $84,360	800 Added 10.65%	8,310 $860,000
Q3 2023 Nov 17, 2023	SELL	$90.94 - $199.54 $115,948 - $254,413	-1,275 Reduced 14.51%	7,510 $683,000
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $246,448 - $272,787	-1,580 Reduced 15.24%	8,785 $1.42 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $266,665 - $320,667	2,015 Added 24.13%	10,365 $1.65 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $437,888 - $577,859	-4,270 Reduced 33.84%	8,350 $1.13 Million
Q3 2022 Nov 09, 2022	BUY	$95.28 - $116.93 $1.2 Million - $1.48 Million	12,620 New	12,620 $1.26 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.